Proteinuria in left ventricular assist device candidates: an emerging risk factor for renal failure and mortality
Over the last decade, advances in left ventricular assist device (LVAD) therapy have revolutionized care of advanced heart failure (HF) patients with excellent long-term survival and quality of life. Approval of LVAD in transplant ineligible patients as destination therapy (DT) allowed for broader application of this technology in older and sicker patient populations. Chronic kidney disease (CKD) is among the most prevalent comorbidities in advanced HF due to coexisting intrinsic renal disease and/or adverse hemodynamics.
Biotechs race to serve patients stuck on waiting lists for organs
Long-term data show better overall survival after an allogeneic transplant for relapsed follicular lymphoma than with autologous transplant, but an expert wonders about recommending transplant at all.Medscape Medical News
Autologous hematopoietic stem cell transplants have increased globally, but predominantly in high income nations, and there are marked disparities in usage.Medscape Medical News
ConclusionsThe factors associated positively with DKT were duration after surgery, improvement of physical activities, mobility, alleviation of pain, and patient satisfaction.
Dylan Mortimer creates celestial and glittery interpretations of scars, lungs and operating rooms.
This article reviews some epidemiological, clinical, diagnostic and therapeutic aspects of these conditions. PMID: 31803301 [PubMed]
"Age has no implication in terms of the antimyeloma effect of transplant," said one oncologist. Researchers called this largest study of auto-HCT in older adults with multiple myeloma.Medscape Medical News
Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter, please visit: https://www.fightaging.org/newsletter/ Longevity Industry Consulting Services Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out m...
A BRAVE three-year-old boy on the transplant register has asked Santa for a new heart, as the NHS launches an appeal for child organ donors this Christmas.